BMY
Bristol-Myers Squibb Company
$65.46
▲ +0.23%
+$0.15
NYSE · Healthcare · Drug Manufacturers - General
· price updated 9h ago
Bristol-Myers Squibb Company
BMY · NYSE · Healthcare · Drug Manufacturers - General · price updated 9h ago
$65.46
▲ +0.23% · +$0.15 today
AI research · $65.46
Track BMY for continuous AI research
price position
Where BMY sits now
52-week range
Low$42.52
High$62.89
Today $65.46
RSI (14)
76.9Overbought
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$11.1B
Total debt$43.1B
Net cash after debt$-32.1B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 48% below Sector avg · favorable
10.23x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.71x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
11.66x
EV / EBITDA
Operating value including debt
Strong · Under 12x operating cash earnings
11.21x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
21.7%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
46.6%
Debt / equity
Balance-sheet leverage
Needs attention · Among weakest in sector
2.02x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
1.53x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How BMY compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $133.41B | 14.4 | +3.1% | 61 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
activity
What is moving BMY
News
- 17h ago · Morgan Stanley via Yahoo Finance
Morgan Stanley uncovers major Bristol Myers stock signals
Bearish 
3d ago · Carvana via Seeking AlphaSA analyst upgrades/downgrades: AAPL, CVNA, BMY, ORCL
Mixed- 3d ago · Seeking Alpha
SA analyst upgrades/downgrades: AAPL, CVNA, BMY, ORCL (BMY:NYSE) - Seeking Alpha
Mixed - 3d ago · Oracle Corporation via Seeking Alpha
SA analyst upgrades/downgrades: AAPL, CVNA, BMY, ORCL
Mixed
US stock research
About Bristol-Myers Squibb Company (BMY) stock
Bristol-Myers Squibb Company tracked in the US core universe. BMY was +0.2% in the latest available session at $65.46. Its reported market value was $133.41B with a trailing P/E of 14.4. Latest reported revenue was $49.19B, changing +3.1% year over year, with $3.32B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $65.46
- Day change
- +0.2%
- Market cap
- $133.41B
- P/E (TTM)
- 14.4
- Revenue growth
- +3.1%
- Industry
- Drug Manufacturers - General